Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Boitano

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
American Journal of Respiratory Cell and Molecular Biology|November 1, 2022
Development of a Novel Mouse Model of Menopause-associated AsthmaWilliam P Pederson, Laurie M Ellerman, Estevan C Sandoval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2013
Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tetheringAndrea N Flynn, Justin Hoffman, Dipti V Tillu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 19, 2018
Protease-activated receptor-2 signaling through β-arrestin-2 mediates Alternaria alkaline serine protease-induced airway inflammationMichael C Yee, Heddie L Nichols, Danny Polley, et al.
British Journal of Pharmacology|November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse modelsCandy M Rivas, Michael C Yee, Kenneth J Addison, et al.
British Journal of Pharmacology|July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivoScott Boitano, Justin Hoffman, Andrea N Flynn, et al.
British Journal of Pharmacology|June 23, 2022
β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammationHillary V Schiff, Candy M Rivas, William P Pederson, et al.
Scientific Reports|December 4, 2021
Myeloid-associated differentiation marker is a novel SP-A-associated transmembrane protein whose expression on airway epithelial cells correlates with asthma severityAlane Blythe C Dy, Paul R Langlais, Natalie K Barker, et al.
JCI Insight|May 1, 2020
The cellular basis of protease-activated receptor 2-evoked mechanical and affective painShayne N Hassler, Moeno Kume, Juliet M Mwirigi, et al.
The Journal of Pain|January 11, 2021
A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide AgonistJuliet Mwirigi, Moeno Kume, Shayne N Hassler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2017
The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic PainJamie K Moy, Arkady Khoutorsky, Marina N Asiedu, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
American Journal of Respiratory Cell and Molecular Biology|November 1, 2022
Development of a Novel Mouse Model of Menopause-associated AsthmaWilliam P Pederson, Laurie M Ellerman, Estevan C Sandoval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2013
Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tetheringAndrea N Flynn, Justin Hoffman, Dipti V Tillu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 19, 2018
Protease-activated receptor-2 signaling through β-arrestin-2 mediates Alternaria alkaline serine protease-induced airway inflammationMichael C Yee, Heddie L Nichols, Danny Polley, et al.
British Journal of Pharmacology|November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse modelsCandy M Rivas, Michael C Yee, Kenneth J Addison, et al.
British Journal of Pharmacology|July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivoScott Boitano, Justin Hoffman, Andrea N Flynn, et al.
British Journal of Pharmacology|June 23, 2022
β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammationHillary V Schiff, Candy M Rivas, William P Pederson, et al.
Scientific Reports|December 4, 2021
Myeloid-associated differentiation marker is a novel SP-A-associated transmembrane protein whose expression on airway epithelial cells correlates with asthma severityAlane Blythe C Dy, Paul R Langlais, Natalie K Barker, et al.
JCI Insight|May 1, 2020
The cellular basis of protease-activated receptor 2-evoked mechanical and affective painShayne N Hassler, Moeno Kume, Juliet M Mwirigi, et al.
The Journal of Pain|January 11, 2021
A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide AgonistJuliet Mwirigi, Moeno Kume, Shayne N Hassler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2017
The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic PainJamie K Moy, Arkady Khoutorsky, Marina N Asiedu, et al.
Pageof 5